Synopex Inc (025320) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Synopex Inc stock KRW 1,596, price KRW 3,055, that is 47.8% below the price, quality 37 out of 100. Rating: strongly overvalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 1,913 KRW – 12,082 KRW · fair‑value band 1,194 KRW – 2,039 KRW · the 3,055 KRW price screens above the 1,596 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 3 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 8, 2026.
Follow Synopex in your weekly email
Every Wednesday you see whether Synopex is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Synopex Inc. manufactures and sells FPCB products and electronic components in South Korea and internationally. It offers electric wires; mask filters; water treatment filters; and membrane filters. The company was founded in 1985 and is based in Pohang, South Korea.
Stock analysis
Synopex Inc (025320) currently trades at 3,055 KRW, while our model-based Fair Value estimate is 1,596 KRW, 48% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 1,986 KRW per share, and 3 of the 23 models we run sit above the 3,055 KRW price.
Bear case: the Asset-Based group reads lowest at 246.19 KRW, and 20 of the 23 models stay below the price. Data coverage for this calculation is low.
Scenario range: 1,194 KRW (bear) to 2,039 KRW (bull), the price of 3,055 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 37/100 (below-average quality), in the Technology sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Synopex Inc reported revenue of 262B KRW in FY2025 versus 232B KRW in FY2021, a compound +3.1%/yr. Reported net income was 7.4B KRW in FY2025, compounding −7.3%/yr from FY2021.
Key figures
Market cap 280B KRW (≈ $207M) Micro · P/S ratio 1.35 · EPS (TTM) −0.3055 KRW · Net margin 0.0% · Return on equity −0.2% · Return on assets (EBIT) 6.1% (5-year average) · Operating margin −3.5% · Revenue (TTM) 238B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).
What moves the price
The share trades about 62% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −7% fair-value upside, at −48%, 025320 screens richer than that median.
Fair Value models
Bear1,194 KRWFair Value 1,596 KRWBull2,039 KRW
Price 3,055 KRW · Downside -47.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.52/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+9.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.9%
Start year 2020 (pandemic). Over 10 years: +2.9% a year
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.0%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−6.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−6.3%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−6.3% vs 1.1%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−3% → 3%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+47.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +44.4% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 653 stocks
Beats the industry median on 3/11 measures
Overall it trails its industry peers.
Valuation
Quality Score37 · Bottom 25%
Fair Value upside−47.8% · Below median
Profitability
Return on assets2.8% · Below median
Net margin (12 months)0.0% · Bottom 25%
Operating margin (12 months)−3.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)−20.5% · Bottom 25%
Balance sheet
Debt / equity0.03× · Below median
Valuation Multiplesvs Electronic Components median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Synopex Inc Fair Value". https://www.fairvalue-calculator.com/stock/025320
Frequently asked questions
Is Synopex Inc (025320) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 1,596 KRW versus a price of 3,055 KRW, about 48% lower (overvalued).
What is the fair value of 025320?
Our model-based fair value for Synopex Inc is 1,596 KRW (as of Nov 8, 2026), built from audited fundamentals. The current price: 3,055 KRW.
What is the quality score of 025320?
Synopex Inc has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Synopex Inc (025320)?
Our model-based price target is the fair value of 1,596 KRW (as of Nov 8, 2026) from 23 valuation models. Cautious scenario 1,194 KRW, optimistic scenario 2,039 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Synopex Inc stock forecast for 2026?
Our models put fair value at 1,596 KRW, about 48% lower versus a price of 3,055 KRW (overvalued). Cautious scenario 1,194 KRW, optimistic scenario 2,039 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Synopex Inc (025320)?
Synopex Inc reported trailing-twelve-month revenue of about 238B KRW (latest available figure, as of Nov 8, 2026).
What growth is priced into Synopex Inc (025320)?
For today's price to be fair in a discounted-cash-flow model, Synopex Inc would have to grow free cash flow by +47.4 % per year for five years (discount rate 12.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.0 % per year. Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of 025320 use?
Our models discount Synopex Inc at 12.4 %: a base by market capitalisation (micro), damped by beta 0.78, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Synopex Inc that is +47.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.4 %) and the same formula as our fair value.
How much growth has Synopex Inc (025320) delivered so far?
Over the past 5 years revenue at Synopex Inc grew +4.0 % a year. The price currently implies free-cash-flow growth of +47.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Synopex Inc (025320) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into Synopex Inc (+47.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Synopex Inc (025320)?
The free-cash-flow yield on the price is 1.10 % in the last fiscal year (free cash flow was negative over the last twelve months): that much free cash flow Synopex Inc produces per unit of market value. When it exceeds the discount rate of our models (12.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Synopex Inc (025320)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Synopex Inc it is 1,596 KRW per share (as of Nov 8, 2026), against a price of 3,055 KRW. It is the blended result of 23 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Synopex Inc stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 025320 trades above its calculated fair value: price 3,055 KRW, fair value 1,596 KRW, a gap of about −48% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 025320?
No. The price is what the market pays today (3,055 KRW); the fair value is what the company's own numbers justify (1,596 KRW). For Synopex Inc the two are 1,459 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Synopex Inc worth?
The market values Synopex Inc at about 280B KRW (market capitalisation, as of Nov 8, 2026). Per share that is 3,055 KRW; our models calculate a fair value of 1,596 KRW per share.
What do the bullish and bearish scenarios say about 025320?
Our models span a range for Synopex Inc: cautious scenario 1,194 KRW, base 1,596 KRW, optimistic 2,039 KRW per share (as of Nov 8, 2026, price 3,055 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Synopex Inc (025320)?
Balance-sheet figures for Synopex Inc (as of Nov 8, 2026): return on equity −0.2%, debt of 0.03 per unit of equity. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is 025320 from its 52-week high?
Synopex Inc trades at 3,055 KRW, about 62% below its 52-week high of 7,990 KRW and at the low of 3,055 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 1,596 KRW is for.
Which stocks are comparable to Synopex Inc?
From the same area (Technology) we also value Amphenol Corporation, Hon Hai Precision Industry Co, Corning Incorporated, Delta Electronics, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Synopex Inc stock attractive at the current price?
The data as of Nov 8, 2026: price 3,055 KRW, calculated fair value 1,596 KRW (−48%), Quality Score 37/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 025320 calculated?
We run Synopex Inc through 23 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 1,596 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Synopex Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Synopex Inc (025320)?
The closing price on Nov 6, 2026 was 3,055 KRW. Our model-based fair value is 1,596 KRW, about 48% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Synopex Inc right now?
The price sits above even our optimistic bull case (2,039 KRW). The favourable scenario is already priced in. Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Synopex Inc
How large is the market capitalisation of Synopex Inc (025320)?
The market capitalisation of Synopex Inc is 280B KRW (≈ $207M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Synopex Inc (025320)?
The price-to-sales ratio of Synopex Inc is 1.35 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Synopex Inc (025320)?
Earnings per share at Synopex Inc are −0.3055 KRW. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Synopex Inc (025320)?
The net margin of Synopex Inc is 0.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Synopex Inc (025320)?
The return on equity (ROE) of Synopex Inc is −0.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Synopex Inc (025320)?
On an EBIT basis the return on assets of Synopex Inc is 6.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Synopex Inc (025320)?
The operating margin of Synopex Inc is −3.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Synopex Inc (025320)?
Revenue at Synopex Inc is growing −20.5% versus a year earlier (3y avg +2.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Synopex Inc (025320)?
Earnings per share at Synopex Inc are growing −47.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Synopex Inc (025320) carry?
The net debt of Synopex Inc is 2.9B KRW (fiscal year 2023, ≈ 0.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Synopex Inc in the live analysis
One click puts Synopex Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 8, 2026